(7-182) Age-Based Analysis of Bruton Tyrosine Kinase Inhibitor (BTKi) Prescribing, Health Outcomes, and Healthcare Utilization for Veterans with Mantle Cell Lymphoma in the Veterans Affairs System
Tuesday, December 10, 2024
12:00 PM – 1:00 PM
Location: Hall G, Lower Level
Category: Evaluative Study Topic: Oncology/Hematology
Co-Author(s): Corbyn M. Gilmore, Henry Ogbeifun, Adriana Vargus, Christopher R. Frei
